(Reumatizam[TA])
1,051 results
  • [CRYOGLOBULINEMICVASCULITIS AS A MANIFESTATION OF PARANEOPLASTIC SYNDROME--A CASE REPORT]. [Case Reports]
    Reumatizam. 2015; 62(1):27-30.Milas-Ahić J, Prus V, … Kardum ZR
  • Cryoglobulinemia refers to the presence of circulating cryoglobulins in the serum which may lead to organ damage and systemic response characterized by fatigue, arthralgias, purpura, glomerulonephritis and neuropathy. The disease mainly affects small and medium-sized blood vessels and causes vasculitis due to cryoglobulin-containing immune complexes. Mixed cryoglobulinemia (type I and II) are mos…
  • [PATHOGENESIS OF UNDIFFERENTIATED SPONDYLOARTHRITIS]. [Journal Article]
    Reumatizam. 2015; 62(1):20-6.Lamot L, Vidović M, … Harjacek MR
  • Spondyloarthritis or spondyloarthropathy (SpA) is a multifactorial disease in which a disturbed interplay occurs between the immune system and environmental factors on a predisposing genetic background, which leads to inflammation and structural damage of target tissue. Many recent researches on development of SpA showed important role of innate and adaptive immunity as well as of prominent bone …
  • [TAKAYASU ARTERITIS AND POSSIBLE CARDIOLOGY REPERCUSSIONS IN THE CHILDHOOD]. [Case Reports]
    Reumatizam. 2015; 62(2):22-6.Malcić I, Detoni P, … Jelusić MR
  • Vasculitides are rare rheumatic diseases of unknown etiology whose main characteristic is a necrotizing inflammation of blood vessels. We are presenting two patients with Takayasu arteritis (TA) as entity forms of rare rheumatic diseases. One patient had TA type IIa and the other type IV. In the first patient we found severe symptoms of obstructive lesions of aortic branches, particularly severe …
  • [BONE MINERAL DENSITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS--OUR RESULTS]. [Journal Article]
    Reumatizam. 2015; 62(2):16-21.Gracanin AG, Marković I, … Morović-Vergles JR
  • CONCLUSIONS: The etiopathogenesis of decreased BMD in SLE patients is multifactorial and includes both traditional and SLE-related risk factors. In our group of SLE patients age and glucocorticoid treatment were the major risk factors for LBM. Timely prevention and treatment of LBM and osteoporosis in SLE patients, according to current knowledge, are essential for reducing morbidity and mortality.